These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13688656)

  • 1. Clinical experience with actinomycin C.
    BEGEMANN H
    Ann N Y Acad Sci; 1960 Oct; 89():454-62. PubMed ID: 13688656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of lymphatic system diseases with actinomycin C].
    BEGEMANN H
    G Ital Chemioter; 1956; 3(3-4):517-22. PubMed ID: 13462199
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic control of systemic diseases, leukemic lymphadenosis, lymphogranulomatosis, mycosis fungoides, so-called reticulosarcomatosis by actinomycin C].
    FUNK CF; KROBER F
    Arch Klin Exp Dermatol; 1957; 206():666-74; discussion 674-6. PubMed ID: 13522105
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of the effect of degranol.
    SANDOR L; CERNY V; UJHAZY V; WINKLER A
    Neoplasma; 1959; 6():179-82. PubMed ID: 14441442
    [No Abstract]   [Full Text] [Related]  

  • 5. [On dopan therapy of patients with lymphogranulomatosis, chronic lymphatic leukemia and other systemic blood diseases].
    PETROV KIa
    Sov Med; 1961 Nov; 25():13-7. PubMed ID: 14485925
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimentation with actinomycin].
    HUGUENIN R; TRUHAUT R; BOURDIN JS
    Presse Med (1893); 1954 May; 62(35):740. PubMed ID: 13177453
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of uracil mustard in chronic lymphatic leukemia and malignant lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    Cancer Chemother Rep; 1961 Apr; 11():77-80. PubMed ID: 13752495
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of malignant lymphomas and lymphadenoses with leukeran.
    LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J
    Neoplasma; 1959; 6():415-24. PubMed ID: 14416684
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotics in the control of Hodgkin's disease and the leukemias.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1962 Sep; 134():334-45. PubMed ID: 13976142
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of irradiation of the diencephalon].
    ZIERHUT E
    Wien Med Wochenschr; 1955 Aug; 105(32-33):659-62. PubMed ID: 13257217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    BERNARD J; MATHE G; WEIL M
    Sang; 1957; 28(1):80-2. PubMed ID: 13432604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value and action of cytostatics in malignant lymphatic system diseases].
    FLEISCHHACKER H; STACHER A
    Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical use of triethylene melamine.
    KRAVITZ SC; DIAMOND HD; CRAVER LF
    Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A; LASCH HG
    Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
    [No Abstract]   [Full Text] [Related]  

  • 15. [First experiences with sanamycin (actinomycin C) in lymphogranulomatosis and leukemia].
    OTTO H
    Z Gesamte Inn Med; 1955 Oct; 10(19):913-8. PubMed ID: 13300326
    [No Abstract]   [Full Text] [Related]  

  • 16. Triethylene melamine in the treatment of neoplastic disease.
    RUNDLES RW; BARTON WB
    Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
    BERNARD J; MATHE G; WEIL M
    Rev Fr Etud Clin Biol; 1956 Dec; 1(10):1121-32. PubMed ID: 13408766
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 19. [When to terminate the treatment of children with Hodgkin's disease, lymphoblastic leukemia and non-Hodgkin's lymphoma. Analysis of 80 cases].
    Armata J
    Pediatr Pol; 1979 Aug; 54(8):877-85. PubMed ID: 291888
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
    FALKSON G; SNYMAN HJ
    Acta Unio Int Contra Cancrum; 1964; 20():439-46. PubMed ID: 14155998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.